IP Library Assignment 039897/0053
Patent Assignment
Reel/Frame 039897/0053

Change of Name

Recorded: 2016-09-01 Pages: 4
Assignor
TARGACEPT, INC.
Executed: 2015-08-20
Assignee
CATALYST BIOSCIENCES, INC.
260 LITTLEFIELD AVE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (3)
(2S,3R)-N-(2-((3-Pyridinyl)Methyl)-1-Azabicyclo[2.2.2]Oct-3-Yl)Benzofuran-2-Carboxamide, Novel Salt Forms, and Methods of Use Thereof
Application: 14/467,289 →
Publication: US 2015/0045386
Preparation and Therapeutic Applications of (2S,3R)-N-2-((3-Pyridinyl)Methyl)-1-Azabicyclo[2.2.2]Oct-3-Yl)-3,5-Difluorobenzamide
Application: 14/867,133 →
Publication: US 2017/0119746
Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes
Patent: 9,580,434 →
Application: 14/922,473 →
Publication: US 2016/0039833
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 30, 2016
From: CATALYST BIOSCIENCES, INC.
To: ATTENUA, INC.
Reel/Frame 039585/0675 →
Assignment of Assignor's Interest Sep 1, 2016
From: CATALYST BIOSCIENCES, INC.
To: ATTENUA, INC.
Reel/Frame 039615/0222 →